ST. LOUIS, Sept. 9, 2025 /PRNewswire/ -- Panome Bio, a leading provider of multi-omic services, announced a first of its kind commercial offering applying their leading discovery metabolomics ...
The results of their study were published online in Translational Medicine. “The cancer research community is greatly interested in accurately identifying and characterizing genome amplifications and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback